Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Breast Cancer Organoids × Endostatins × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 20 Nasopharyngeal Carcinoma 7 Colorectal Neoplasms 4 Breast Neoplasms 4 Uterine Cervical Neoplasms 3 Nasopharyngeal Neoplasms 3 Lung Neoplasms 3 Unspecified Adult Solid Tumor, Protocol Specific 2 Sarcoma 2 Recurrence 2 Neoplasms 2 Head and Neck Neoplasms 2 Unresectable Non-small Cell Lung Cancer 1 Squamous Non-small Cell Lung Cancer 1 Squamous Non-Small Cell Lung Cancer SqNSCLC 1 Solid Tumors 1 Optic Nerve Glioma 1 Neuroma, Acoustic 1 Neurofibromatosis 2 1 Neuroblastoma 1 Meningeal Carcinomatosis 1 Melanoma 1 Lymphoma, T-Cell 1 Locally Advanced Squamous Non-small Cell Lung Cancer 1 Glioblastoma 1 Gastrointestinal Neoplasms 1 Esophageal Squamous Cell Carcinoma 1 Esophageal Neoplasms 1 Carcinoma, Hepatocellular 1 Breast Cancer Organoids 1

Interventions

pyrrolidine 1 pirarubicin 1 olaparib 1 ixabepilone 1 exemestane 1 eribulin 1 apatinib 1 Vinorelbine 1 Trastuzumab 1 Toremifene 1 Tamoxifen 1 Paclitaxel 1 Methotrexate 1 Letrozole 1 Gemcitabine 1 Fulvestrant 1 Fluorouracil 1 Epirubicin 1 Endostatins 1 Doxorubicin 1 Cyclophosphamide 1 Cisplatin 1 Carboplatin 1 Capecitabine 1 Bevacizumab 1 Anastrozole 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03925233 2019-04-24

Breast Cancer Treatment Based on Organ-like Culture

Xijing Hospital

Breast Cancer Organoids

Data powered by HemOnc (CC BY 4.0) Colophon ⚡